Clinical Trial Update: Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of an aminoflavone prodrug for breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aminoflavone prodrug (aminoflavone prodrug)

Snippet

Sponsor: Tigris Pharmaceuticals | Conditions: Breast Neoplasm | Phase 2 | Status: WITHDRAWN